TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Joo Hyun O et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.